⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31504163 | 1.00 | — | — | |
| SCHEMBL15316464 | 0.78 | — | — | |
| SCHEMBL13429608 | 0.78 | — | — | |
| SCHEMBL4884569 | 0.73 | — | — | |
| SCHEMBL5335819 | 0.73 | — | — | |
| SCHEMBL25835951 | 0.69 | F10 (0.33) | — | |
| SCHEMBL30962430 | 0.68 | — | — | |
| SCHEMBL19889456 | 0.68 | — | — | |
| SCHEMBL7941683 | 0.68 | — | — | |
| SCHEMBL20043694 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025083472-A2 | PROTAC COMPOUNDS BINDING KEAP1 UBIQUITIN LIGASE FOR TARGETED PROTEIN DEGRADATION | SEED THERAPEUTICS US, INC. (US) | 2025-04-24 | — | — | WO | disclosed |